New cancer clinical trial: Study of Anlotinib in Patients With Primary Malignant Bone Tumors

Published on: May 17, 2018 at 12:00PM
Condition:   Neoplasm of Bone
Intervention:   Drug: Anlotinib
Sponsor:   Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Not yet recruiting
https://ift.tt/2GrGkhO